Chinese english Germany Japanese Korea

(2S,5R)-7-oxo-N-[(3S,4R)-3-fluoropiperidin-4-yl]-6-(sulfooxy)-1,6-diazabicyclo[3.2.1]octane-2-carboxamide

(2S,5R)-7-oxo-N-[(3S,4R)-3-fluoropiperidin-4-yl]-6-(sulfooxy)-1,6-diazabicyclo[3.2.1]octane-2-carboxamide Struktur
1174019-21-6
CAS-Nr.
1174019-21-6
Englisch Name:
(2S,5R)-7-oxo-N-[(3S,4R)-3-fluoropiperidin-4-yl]-6-(sulfooxy)-1,6-diazabicyclo[3.2.1]octane-2-carboxamide
Synonyma:
Ademetionine 1,4-Butanedisulfonate Impurity 32;(2S,5R)-7-oxo-N-[(3S,4R)-3-fluoropiperidin-4-yl]-6-(sulfooxy)-1,6-diazabicyclo[3.2.1]octane-2-carboxamide;Sulfuric acid, mono[(1R,2S,5R)-2-[[[(3S,4R)-3-fluoro-4-piperidinyl]amino]carbonyl]-7-oxo-1,6-diazabicyclo[3.2.1]oct-6-yl] ester
CBNumber:
CB411631529
Summenformel:
C12H19FN4O6S
Molgewicht:
366.37
MOL-Datei:
1174019-21-6.mol
Request For Quotation

(2S,5R)-7-oxo-N-[(3S,4R)-3-fluoropiperidin-4-yl]-6-(sulfooxy)-1,6-diazabicyclo[3.2.1]octane-2-carboxamide Eigenschaften

Dichte
1?+-.0.1 g/cm3(Predicted)
pka
-4.59±0.18(Predicted)

Sicherheit

(2S,5R)-7-oxo-N-[(3S,4R)-3-fluoropiperidin-4-yl]-6-(sulfooxy)-1,6-diazabicyclo[3.2.1]octane-2-carboxamide Chemische Eigenschaften,Einsatz,Produktion Methoden

(2S,5R)-7-oxo-N-[(3S,4R)-3-fluoropiperidin-4-yl]-6-(sulfooxy)-1,6-diazabicyclo[3.2.1]octane-2-carboxamide Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

(2S,5R)-7-oxo-N-[(3S,4R)-3-fluoropiperidin-4-yl]-6-(sulfooxy)-1,6-diazabicyclo[3.2.1]octane-2-carboxamide Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 1)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Hubei Yangxin Medical Technology Co., Ltd. 15374522761
 3003392093@qq.com China 8289 55
  • (2S,5R)-7-oxo-N-[(3S,4R)-3-fluoropiperidin-4-yl]-6-(sulfooxy)-1,6-diazabicyclo[3.2.1]octane-2-carboxamide
  • Sulfuric acid, mono[(1R,2S,5R)-2-[[[(3S,4R)-3-fluoro-4-piperidinyl]amino]carbonyl]-7-oxo-1,6-diazabicyclo[3.2.1]oct-6-yl] ester
  • Ademetionine 1,4-Butanedisulfonate Impurity 32
  • 1174019-21-6
Copyright 2019 © ChemicalBook. All rights reserved